NYSE$HCA

HCA Holdings Inc · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

HCA Healthcare's Q4 2020 earnings were released, showing increased revenues and net income compared to the previous year.

HCA Healthcare reported strong financial results for Q4 2020, driven by highly acute inpatient volumes and solid cost management. Revenues increased to $14.293 billion, and net income attributable to HCA Healthcare, Inc. totaled $1.426 billion, or $4.13 per diluted share.

  • Revenues totaled $14.293 billion.
  • Net income attributable to HCA Healthcare, Inc. totaled $1.426 billion, or $4.13 per diluted share.
  • Adjusted EBITDA totaled $3.118 billion.
  • Cash flows used in operating activities totaled $3.583 billion, including the return of over $6 billion in CARES Act funds.

Headline financials

Total Revenue

$14.3B

Previous: $13.5B+5.7%
EPS (adj)

$4.13

Previous: $3.09+33.7%
Admissions

521.9K

Previous: 540.2K-3.4%
Number of Hospitals

185

Previous: 184+0.5%
Licensed Beds at End of Period

49.3K

Previous: 49.0K+0.5%
Occupancy

69.1%

Previous: 57.8%+19.6%
Average Length of Stay (days)

5.123

Previous: 4.815+6.4%
Capital Expenditures

$748M

Previous: $1.27B-41.3%
Free Cash Flow

-$4.33B

Previous: $2.51B-272.9%
Net Income

$1.69B

Previous: $1.07B+58.2%
Operating Income

$2.07B

Previous: $1.61B+28.9%
Gross Profit

$11.9B

Previous: $11.3B+5.6%
Cash & Equivalents

$1.79B

Previous: $621M+188.7%
Total Assets

$47.5B

Previous: $45.1B+5.4%
Stock-Based Comp

$133M

Previous: $84M+58.3%

Revenue & EPS history

HCA · Revenue · Quarterly

$14.3B

Q4 2020+5.7%vs Q4 2019
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Forward guidance

The Company issued the following estimated guidance for 2021: Revenues $53.5 to $55.5 billion, Adjusted EBITDA $10.3 to $10.9 billion, EPS (diluted) $12.10 to $13.10 per diluted share and Capital Expenditures Approximately $3.7 billion.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

-0.1%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+2.9%

Avg return

30 days after

47%

31 / 66 earnings

Positive

+16.1%

Q2 2020

Best reaction

-21.9%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-5.2%-8.3%-16.8%
Q4 2025+6.2%+3.4%+11.3%
Q3 2025+1.5%+6.4%+11.6%
Q2 2025+0.8%+3.1%+3.8%
Q1 2025-4.0%+1.1%+10.3%
Q4 2024-3.8%+0.7%-2.7%
Q3 2024-10.6%-9.5%-18.5%
Q2 2024+5.7%+9.0%+17.7%
Q1 2024-0.9%-1.5%+1.5%
Q4 2023+6.3%+7.9%+8.7%
Q3 2023-6.5%-6.5%+5.0%
Q2 2023-3.2%-2.9%-3.2%
Q1 2023+5.7%+2.7%+4.3%
Q4 2022-0.6%+2.6%-2.2%
Q3 2022+0.8%+4.3%+10.3%
Q2 2022+9.6%+12.9%+18.6%
Q1 2022-21.9%-21.2%-24.0%
Q4 2021-1.4%-1.1%+5.5%
Q3 2021-7.0%-5.6%-8.1%
Q2 2021+14.5%+14.2%+13.3%
Q1 2021+2.5%+0.7%+4.5%
Q4 2020+3.7%+5.9%+5.6%
Q3 2020-4.4%-9.3%+12.5%
Q2 2020+16.1%+14.6%+21.2%
Q1 2020-5.4%-2.4%-2.2%
Q4 2019+2.6%-2.0%-10.1%
Q3 2019+6.2%+5.3%+10.3%
Q2 2019-8.7%-13.0%-17.4%
Q1 2019-1.1%+0.2%-2.3%
Q4 2018+5.6%+6.1%+5.5%
Q3 2018+3.5%+4.2%+12.0%
Q2 2018+14.9%+14.7%+21.4%
Q1 2018+2.1%+1.9%+7.7%
Q4 2017+3.6%+2.1%+1.9%
Q3 2017+0.9%+0.3%+11.6%
Q2 2017-5.2%-6.6%-7.9%
Q1 2017-1.2%-0.4%-0.1%
Q4 2016+3.4%+5.7%+10.2%
Q3 2016-2.1%-4.5%-9.6%
Q2 2016-1.1%-3.8%-4.8%
Q1 2016-1.7%
Q4 2015+3.1%
Q3 2015-0.1%
Q2 2015-2.8%
Q1 2015-1.2%
Q4 2014-1.7%
Q3 2014-2.1%
Q2 2014+4.1%
Q1 2014-1.2%
Q4 2013-1.0%
Q3 2013-5.1%
Q2 2013+0.1%
Q1 2013+3.8%
Q4 2012-1.1%
Q3 2012+8.0%
Q2 2012+1.1%
Q1 2012-1.1%
Q4 2009+3.5%
Q4 2011+3.5%
Q3 2011+2.6%
Q3 2010+2.6%
Q2 2011-20.6%
Q2 2010-20.6%
Q1 2011-0.2%
Q1 2010-0.2%
Q4 2010-0.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro